AAAAAA
Results:
1-7
|
Results: 7
Authors:
Mezger, J
Citation: J. Mezger, Nail changes after chemotherapy with taxanes, MED KLIN, 96(8), 2001, pp. 479-479
Authors:
Mezger, J
Citation: J. Mezger, Betrifft Morant, R.: Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer. Onkologie 2001;24,116-121., ONKOLOGIE, 24(4), 2001, pp. 374-374
Authors:
Mezger, J
Citation: J. Mezger, Both sides of Janus, FORTUNE, 143(4), 2001, pp. 32-32
Authors:
Huber, RM
Gatzemeier, U
Gosse, H
von Pawel, J
Hruska, D
Mezger, J
Saal, JG
Kleinschmidt, R
Steppert, C
Steppling, H
Citation: Rm. Huber et al., Topotecan in second-line therapy of SCLC: Impact on survival?, ONKOLOGIE, 23, 2000, pp. 9-12
Authors:
Bender, H
Bangard, N
Metten, N
Bangard, M
Mezger, J
Schomburg, A
Biersack, HJ
Citation: H. Bender et al., Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer, HYBRIDOMA, 18(1), 1999, pp. 87-91
Authors:
Lamerz, R
Stoetzer, OJ
Mezger, J
Brandt, A
Darsow, M
Wilmanns, W
Citation: R. Lamerz et al., Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions, ANTICANC R, 19(4A), 1999, pp. 2421-2425
Authors:
Boland, EA
Grey, M
Mezger, J
Tamborlane, WV
Citation: Ea. Boland et al., A summer vacation from diabetes: Evidence from a clinical trial, DIABET EDUC, 25(1), 1999, pp. 31-40
Risultati:
1-7
|